NOVEMBER, 2006 - Genteomics USAInc. is awarded a prestigious Associate Memebership status in the Early Detection Research Network (EDRN) within the federal agency National Cancer Institute (NCI) under the National Institutes of Health (NIH), USA. As a part of the EDRN membership, Genteomics and its affiliate GIBBA along with their collaborating organizations will take an active role in the mission of Biomarker Discovery and Validation Studies, wherein Genteomics' post-genome technology portfolio and sub-population approach will be key. Genteomics will initially focus on breast cancer and then expand to other forms of cancer